ZRANB1 and colorectal carcinoma: ZRANB1 modulated SOX9 stability in CRC cells by diminishing its ubiquitination, which in turn potentiated the SOX9-mediated USP22/Wnt/β-catenin pathway to uphold CRC stemness characteristics (89).